NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF4 | hg19_v2_chr18_-_53257027_53257052 | -0.95 | 3.8e-03 | Click! |
SNAI2 | hg19_v2_chr8_-_49834299_49834446 | -0.29 | 5.7e-01 | Click! |
ID4 | hg19_v2_chr6_+_19837592_19837621 | -0.17 | 7.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_241835561 | 2.49 |
ENST00000388934.4
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr1_-_47655686 | 1.75 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chrX_+_115567767 | 1.65 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr16_-_74808710 | 1.54 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
chr16_+_88704978 | 1.52 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
chr22_-_50970506 | 1.46 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr11_-_615570 | 1.45 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr6_-_160148356 | 1.43 |
ENST00000401980.3
ENST00000545162.1 |
SOD2
|
superoxide dismutase 2, mitochondrial |
chr6_-_31550192 | 1.30 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr17_+_77021702 | 1.27 |
ENST00000392445.2
ENST00000354124.3 |
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr1_-_153066998 | 1.26 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr11_+_45944190 | 1.25 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
chr19_+_46732988 | 1.24 |
ENST00000437936.1
|
IGFL1
|
IGF-like family member 1 |
chr1_-_153113927 | 1.21 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr1_+_37940153 | 1.20 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr2_+_74212073 | 1.18 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
chr12_-_49259643 | 1.18 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr2_+_113735575 | 1.17 |
ENST00000376489.2
ENST00000259205.4 |
IL36G
|
interleukin 36, gamma |
chr7_+_149416439 | 1.13 |
ENST00000497895.1
|
KRBA1
|
KRAB-A domain containing 1 |
chr19_+_6464502 | 1.11 |
ENST00000308243.7
|
CRB3
|
crumbs homolog 3 (Drosophila) |
chr6_-_160147925 | 1.10 |
ENST00000535561.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr22_-_50970566 | 1.07 |
ENST00000405135.1
ENST00000401779.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr11_+_102188224 | 1.07 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr18_+_61564389 | 0.98 |
ENST00000397996.2
ENST00000418725.1 |
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
chr16_+_771663 | 0.98 |
ENST00000568916.1
|
FAM173A
|
family with sequence similarity 173, member A |
chr19_+_6464243 | 0.96 |
ENST00000600229.1
ENST00000356762.3 |
CRB3
|
crumbs homolog 3 (Drosophila) |
chr1_-_27998689 | 0.94 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr2_+_228678550 | 0.93 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr11_-_1619524 | 0.91 |
ENST00000412090.1
|
KRTAP5-2
|
keratin associated protein 5-2 |
chr6_-_133055896 | 0.85 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
chr21_+_42792442 | 0.85 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr11_+_102188272 | 0.83 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr14_+_95078714 | 0.83 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr6_-_133055815 | 0.81 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr5_-_150466692 | 0.81 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr7_+_76109827 | 0.80 |
ENST00000446820.2
|
DTX2
|
deltex homolog 2 (Drosophila) |
chr20_+_44035200 | 0.80 |
ENST00000372717.1
ENST00000360981.4 |
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr17_+_73521763 | 0.79 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
chr1_-_1009683 | 0.79 |
ENST00000453464.2
|
RNF223
|
ring finger protein 223 |
chr5_+_443280 | 0.79 |
ENST00000508022.1
|
EXOC3
|
exocyst complex component 3 |
chr11_+_93754513 | 0.77 |
ENST00000315765.9
|
HEPHL1
|
hephaestin-like 1 |
chr11_+_69061594 | 0.76 |
ENST00000441339.2
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
chr6_-_47445214 | 0.74 |
ENST00000604014.1
|
RP11-385F7.1
|
RP11-385F7.1 |
chr5_-_150467221 | 0.73 |
ENST00000522226.1
|
TNIP1
|
TNFAIP3 interacting protein 1 |
chr8_+_145438870 | 0.72 |
ENST00000527931.1
|
FAM203B
|
family with sequence similarity 203, member B |
chr7_+_44788430 | 0.71 |
ENST00000457123.1
ENST00000309315.4 |
ZMIZ2
|
zinc finger, MIZ-type containing 2 |
chr1_-_153013588 | 0.71 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
chr1_-_1850697 | 0.70 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
chr9_-_86955598 | 0.70 |
ENST00000376238.4
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3 |
chr19_+_18747775 | 0.67 |
ENST00000300976.4
ENST00000595182.1 ENST00000599006.1 |
KLHL26
|
kelch-like family member 26 |
chr11_-_65667884 | 0.66 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr2_-_241836298 | 0.66 |
ENST00000414499.1
|
C2orf54
|
chromosome 2 open reading frame 54 |
chr22_+_31090793 | 0.66 |
ENST00000332585.6
ENST00000382310.3 ENST00000446658.2 |
OSBP2
|
oxysterol binding protein 2 |
chr21_+_42798094 | 0.66 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr2_-_133427767 | 0.65 |
ENST00000397463.2
|
LYPD1
|
LY6/PLAUR domain containing 1 |
chr1_+_152486950 | 0.64 |
ENST00000368790.3
|
CRCT1
|
cysteine-rich C-terminal 1 |
chr11_-_65667997 | 0.63 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr11_-_615942 | 0.63 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr6_-_3227877 | 0.61 |
ENST00000259818.7
|
TUBB2B
|
tubulin, beta 2B class IIb |
chr21_+_39628780 | 0.61 |
ENST00000417042.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr11_-_18258342 | 0.61 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr14_+_105927191 | 0.60 |
ENST00000550551.1
|
MTA1
|
metastasis associated 1 |
chr10_+_102891048 | 0.60 |
ENST00000467928.2
|
TLX1
|
T-cell leukemia homeobox 1 |
chr12_-_48276710 | 0.58 |
ENST00000550314.1
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor |
chr17_-_72968809 | 0.58 |
ENST00000530857.1
ENST00000425042.2 |
HID1
|
HID1 domain containing |
chr19_+_34895289 | 0.58 |
ENST00000246535.3
|
PDCD2L
|
programmed cell death 2-like |
chr4_-_54457783 | 0.58 |
ENST00000263925.7
ENST00000512247.1 |
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
chr1_-_153348067 | 0.58 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr11_+_64004888 | 0.57 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr4_-_74964904 | 0.56 |
ENST00000508487.2
|
CXCL2
|
chemokine (C-X-C motif) ligand 2 |
chr19_+_40873617 | 0.55 |
ENST00000599353.1
|
PLD3
|
phospholipase D family, member 3 |
chr19_+_49055332 | 0.55 |
ENST00000201586.2
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1 |
chr14_-_55369525 | 0.55 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
chr22_+_38609538 | 0.54 |
ENST00000407965.1
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr3_+_111393501 | 0.54 |
ENST00000393934.3
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
chr14_-_50999373 | 0.54 |
ENST00000554273.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
chr1_+_6508571 | 0.54 |
ENST00000478323.1
|
ESPN
|
espin |
chr17_-_39942322 | 0.54 |
ENST00000449889.1
ENST00000465293.1 |
JUP
|
junction plakoglobin |
chr2_-_241831424 | 0.53 |
ENST00000402775.2
ENST00000307486.8 |
C2orf54
|
chromosome 2 open reading frame 54 |
chr1_-_153433120 | 0.53 |
ENST00000368723.3
|
S100A7
|
S100 calcium binding protein A7 |
chr2_-_241396106 | 0.53 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr11_+_44587141 | 0.52 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
chr16_+_4784273 | 0.52 |
ENST00000299320.5
ENST00000586724.1 |
C16orf71
|
chromosome 16 open reading frame 71 |
chr19_+_39647271 | 0.51 |
ENST00000599657.1
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4 |
chr8_-_145086922 | 0.50 |
ENST00000530478.1
|
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr12_-_25150373 | 0.50 |
ENST00000549828.1
|
C12orf77
|
chromosome 12 open reading frame 77 |
chr7_-_752577 | 0.50 |
ENST00000544935.1
ENST00000430040.1 ENST00000456696.2 ENST00000406797.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
chr11_-_31531121 | 0.49 |
ENST00000532287.1
ENST00000526776.1 ENST00000534812.1 ENST00000529749.1 ENST00000278200.1 ENST00000530023.1 ENST00000533642.1 |
IMMP1L
|
IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
chr15_-_80263506 | 0.49 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr16_+_3115378 | 0.49 |
ENST00000529550.1
ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32
|
interleukin 32 |
chr17_+_77020325 | 0.49 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr12_+_113376157 | 0.49 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr7_-_994302 | 0.48 |
ENST00000265846.5
|
ADAP1
|
ArfGAP with dual PH domains 1 |
chr17_-_47925379 | 0.48 |
ENST00000352793.2
ENST00000334568.4 ENST00000398154.1 ENST00000436235.1 ENST00000326219.5 |
TAC4
|
tachykinin 4 (hemokinin) |
chr3_-_111314230 | 0.48 |
ENST00000317012.4
|
ZBED2
|
zinc finger, BED-type containing 2 |
chr7_-_73184588 | 0.48 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
chr12_-_89918982 | 0.48 |
ENST00000549504.1
|
POC1B
|
POC1 centriolar protein B |
chr19_-_37178284 | 0.47 |
ENST00000425254.2
ENST00000590952.1 ENST00000433232.1 |
AC074138.3
|
AC074138.3 |
chr4_+_74606223 | 0.47 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr1_+_10057274 | 0.47 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
chr18_+_66382428 | 0.47 |
ENST00000578970.1
ENST00000582371.1 ENST00000584775.1 |
CCDC102B
|
coiled-coil domain containing 102B |
chr6_+_106534192 | 0.47 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr16_+_89989687 | 0.46 |
ENST00000315491.7
ENST00000555576.1 ENST00000554336.1 ENST00000553967.1 |
TUBB3
|
Tubulin beta-3 chain |
chr14_+_96949319 | 0.46 |
ENST00000554706.1
|
AK7
|
adenylate kinase 7 |
chr3_+_49059038 | 0.46 |
ENST00000451378.2
|
NDUFAF3
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 |
chr14_+_77582905 | 0.46 |
ENST00000557408.1
|
TMEM63C
|
transmembrane protein 63C |
chr12_+_122667658 | 0.46 |
ENST00000339777.4
ENST00000425921.1 |
LRRC43
|
leucine rich repeat containing 43 |
chr9_+_33795533 | 0.46 |
ENST00000379405.3
|
PRSS3
|
protease, serine, 3 |
chr16_+_811073 | 0.46 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
chr16_+_3062457 | 0.46 |
ENST00000445369.2
|
CLDN9
|
claudin 9 |
chr4_-_74904398 | 0.46 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr17_+_77030267 | 0.45 |
ENST00000581774.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr17_+_77020224 | 0.45 |
ENST00000339142.2
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr14_+_21492331 | 0.45 |
ENST00000533984.1
ENST00000532213.2 |
AL161668.5
|
AL161668.5 |
chr6_-_160166218 | 0.45 |
ENST00000537657.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr14_+_66578299 | 0.45 |
ENST00000554187.1
ENST00000556662.1 ENST00000556291.1 ENST00000557723.1 ENST00000557050.1 |
RP11-783L4.1
|
RP11-783L4.1 |
chr19_-_43835582 | 0.44 |
ENST00000595748.1
|
CTC-490G23.2
|
CTC-490G23.2 |
chr21_+_42797958 | 0.44 |
ENST00000419044.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr2_+_64681219 | 0.43 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
chr18_+_47088401 | 0.43 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
chr14_+_103592636 | 0.43 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr12_+_113354341 | 0.43 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chrX_-_152939252 | 0.43 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr20_+_44637526 | 0.43 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr16_+_30387141 | 0.43 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr22_+_31489344 | 0.43 |
ENST00000404574.1
|
SMTN
|
smoothelin |
chr12_-_62653903 | 0.42 |
ENST00000552075.1
|
FAM19A2
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 |
chr16_-_4039001 | 0.42 |
ENST00000576936.1
|
ADCY9
|
adenylate cyclase 9 |
chr17_+_41158742 | 0.42 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr19_-_49118067 | 0.42 |
ENST00000593772.1
|
FAM83E
|
family with sequence similarity 83, member E |
chr9_+_91150016 | 0.42 |
ENST00000375854.3
ENST00000375855.3 |
NXNL2
|
nucleoredoxin-like 2 |
chr1_+_10490127 | 0.41 |
ENST00000602787.1
ENST00000602296.1 ENST00000400900.2 |
APITD1
APITD1-CORT
|
apoptosis-inducing, TAF9-like domain 1 APITD1-CORT readthrough |
chr16_-_2770216 | 0.41 |
ENST00000302641.3
|
PRSS27
|
protease, serine 27 |
chr8_-_144654918 | 0.41 |
ENST00000529971.1
|
MROH6
|
maestro heat-like repeat family member 6 |
chr1_-_153363452 | 0.41 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr1_+_2160134 | 0.41 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr7_-_8302298 | 0.41 |
ENST00000446305.1
|
ICA1
|
islet cell autoantigen 1, 69kDa |
chr11_+_107650219 | 0.40 |
ENST00000398067.1
|
AP001024.1
|
Uncharacterized protein |
chr20_+_43803517 | 0.40 |
ENST00000243924.3
|
PI3
|
peptidase inhibitor 3, skin-derived |
chr1_-_11118896 | 0.40 |
ENST00000465788.1
|
SRM
|
spermidine synthase |
chr19_+_50691437 | 0.40 |
ENST00000598205.1
|
MYH14
|
myosin, heavy chain 14, non-muscle |
chr8_+_126010739 | 0.40 |
ENST00000523430.1
ENST00000265896.5 |
SQLE
|
squalene epoxidase |
chr22_-_50970919 | 0.40 |
ENST00000329363.4
ENST00000437588.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr6_-_133035185 | 0.40 |
ENST00000367928.4
|
VNN1
|
vanin 1 |
chr19_+_46531127 | 0.40 |
ENST00000601033.1
|
CTC-344H19.4
|
CTC-344H19.4 |
chr6_+_31895480 | 0.40 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr19_+_2096868 | 0.40 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
chr3_+_167453493 | 0.40 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr17_+_7942424 | 0.40 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr16_-_3086927 | 0.39 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
chr6_-_2842219 | 0.39 |
ENST00000380739.5
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
chr13_-_20767037 | 0.39 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
chr3_+_14474178 | 0.39 |
ENST00000452775.1
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6 |
chr11_-_417308 | 0.39 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr7_-_2883928 | 0.39 |
ENST00000275364.3
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12 |
chr2_-_165477971 | 0.39 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
chr16_-_4784128 | 0.39 |
ENST00000592711.1
ENST00000590147.1 ENST00000304283.4 ENST00000592190.1 ENST00000589065.1 ENST00000585773.1 ENST00000450067.2 ENST00000592698.1 ENST00000586166.1 ENST00000586605.1 ENST00000592421.1 |
ANKS3
|
ankyrin repeat and sterile alpha motif domain containing 3 |
chr16_-_31076332 | 0.39 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
chr6_+_30851205 | 0.39 |
ENST00000515881.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr11_+_313503 | 0.38 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr22_+_41697520 | 0.38 |
ENST00000352645.4
|
ZC3H7B
|
zinc finger CCCH-type containing 7B |
chr22_+_42665742 | 0.38 |
ENST00000332965.3
ENST00000415205.1 ENST00000446578.1 |
Z83851.3
|
Z83851.3 |
chr3_+_167453026 | 0.38 |
ENST00000472941.1
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
chr19_+_35739280 | 0.38 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr1_-_153029980 | 0.38 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr1_-_739137 | 0.38 |
ENST00000599533.1
|
AL669831.1
|
Uncharacterized protein |
chr2_+_223289208 | 0.38 |
ENST00000321276.7
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2 |
chr1_-_40237020 | 0.38 |
ENST00000327582.5
|
OXCT2
|
3-oxoacid CoA transferase 2 |
chr11_-_67397371 | 0.38 |
ENST00000376693.2
ENST00000301490.4 |
NUDT8
|
nudix (nucleoside diphosphate linked moiety X)-type motif 8 |
chr19_+_3721719 | 0.38 |
ENST00000589378.1
ENST00000382008.3 |
TJP3
|
tight junction protein 3 |
chr12_-_110318226 | 0.38 |
ENST00000544393.1
|
GLTP
|
glycolipid transfer protein |
chr17_-_18160584 | 0.37 |
ENST00000581349.1
ENST00000473425.2 |
FLII
|
flightless I homolog (Drosophila) |
chr7_-_131241361 | 0.37 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
chr8_-_79717750 | 0.37 |
ENST00000263851.4
ENST00000379113.2 |
IL7
|
interleukin 7 |
chr11_+_64879317 | 0.37 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
chr22_-_42765174 | 0.37 |
ENST00000432473.1
ENST00000412060.1 ENST00000424852.1 |
Z83851.1
|
Z83851.1 |
chr4_+_74735102 | 0.37 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr15_+_45722727 | 0.37 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
chr19_+_35739597 | 0.37 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
chr3_-_50383096 | 0.37 |
ENST00000442887.1
ENST00000360165.3 |
ZMYND10
|
zinc finger, MYND-type containing 10 |
chr1_-_24126023 | 0.37 |
ENST00000429356.1
|
GALE
|
UDP-galactose-4-epimerase |
chr3_-_156534754 | 0.37 |
ENST00000472943.1
ENST00000473352.1 |
LINC00886
|
long intergenic non-protein coding RNA 886 |
chrX_-_153279697 | 0.36 |
ENST00000444254.1
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr17_+_43299241 | 0.36 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chr19_-_6670128 | 0.36 |
ENST00000245912.3
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14 |
chr12_+_58148842 | 0.36 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
chr2_-_220118631 | 0.36 |
ENST00000248437.4
|
TUBA4A
|
tubulin, alpha 4a |
chr19_+_54960790 | 0.36 |
ENST00000443957.1
|
LENG8
|
leukocyte receptor cluster (LRC) member 8 |
chr21_+_42798124 | 0.36 |
ENST00000417963.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr6_+_126240442 | 0.36 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr4_-_101111615 | 0.36 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
chr6_+_31895467 | 0.36 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr17_-_74497432 | 0.36 |
ENST00000590288.1
ENST00000313080.4 ENST00000592123.1 ENST00000591255.1 ENST00000585989.1 ENST00000591697.1 ENST00000389760.4 |
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila) |
chr19_-_40732594 | 0.36 |
ENST00000430325.2
ENST00000433940.1 |
CNTD2
|
cyclin N-terminal domain containing 2 |
chr19_-_51538148 | 0.35 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
chr1_-_17338386 | 0.35 |
ENST00000341676.5
ENST00000452699.1 |
ATP13A2
|
ATPase type 13A2 |
chr12_-_1703331 | 0.35 |
ENST00000339235.3
|
FBXL14
|
F-box and leucine-rich repeat protein 14 |
chr6_+_31916733 | 0.35 |
ENST00000483004.1
|
CFB
|
complement factor B |
chr19_+_535835 | 0.35 |
ENST00000607527.1
ENST00000606065.1 |
CDC34
|
cell division cycle 34 |
chr15_+_89182178 | 0.35 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.2 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.6 | 2.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.4 | 1.1 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.4 | 2.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 1.8 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 0.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.3 | 0.9 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.2 | 1.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.7 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.2 | 1.0 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.2 | 1.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.2 | 1.1 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.2 | 1.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 0.8 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 0.5 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.9 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.1 | 1.0 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 1.9 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.9 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.6 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 2.9 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.7 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 2.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.5 | GO:2000359 | negative regulation of fertilization(GO:0060467) acrosomal vesicle exocytosis(GO:0060478) regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.1 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) regulation of amyloid precursor protein catabolic process(GO:1902991) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 1.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.9 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.4 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.6 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.9 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 0.3 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.1 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 1.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.2 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.3 | GO:0097187 | dentinogenesis(GO:0097187) |
0.1 | 1.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.1 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.2 | GO:0051592 | response to calcium ion(GO:0051592) |
0.1 | 0.4 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 6.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 0.3 | GO:0072289 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) metanephric nephron tubule formation(GO:0072289) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 2.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.4 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.3 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.2 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.2 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.3 | GO:1903823 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 0.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.4 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.4 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 0.3 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.1 | 0.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 0.4 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.1 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.4 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 0.4 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.1 | 0.3 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.5 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0032796 | uropod organization(GO:0032796) |
0.1 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.4 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 1.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 0.2 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.1 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.1 | 0.2 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.1 | 0.2 | GO:0010983 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 0.5 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.2 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.1 | 0.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.2 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.2 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.1 | 0.2 | GO:0090678 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) presynaptic active zone organization(GO:1990709) |
0.0 | 0.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 1.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.0 | 0.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.0 | 0.1 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.2 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
0.0 | 0.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 0.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.0 | 1.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.4 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.0 | 0.1 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.0 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.0 | 0.3 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.0 | 0.2 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0018201 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.2 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
0.0 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.5 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.1 | GO:2000979 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) negative regulation of bile acid biosynthetic process(GO:0070858) acinar cell differentiation(GO:0090425) negative regulation of bile acid metabolic process(GO:1904252) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.0 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.0 | 0.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.0 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.7 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.0 | 0.1 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.0 | 0.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 0.1 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.0 | 0.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.3 | GO:0035900 | response to isolation stress(GO:0035900) |
0.0 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.2 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.8 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.0 | 0.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) acetylcholine secretion(GO:0061526) |
0.0 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.0 | GO:0048320 | axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.1 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.0 | 1.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.3 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.0 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.2 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.0 | 0.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.0 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:2000542 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.0 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.0 | 0.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.0 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 0.1 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.0 | 0.1 | GO:0007009 | plasma membrane organization(GO:0007009) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.8 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.8 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.0 | 0.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.1 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.0 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.0 | 0.3 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.3 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.1 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.0 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.0 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.0 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.0 | 0.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.0 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0042033 | chemokine biosynthetic process(GO:0042033) |
0.0 | 0.1 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.0 | 0.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.1 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
0.0 | 0.2 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.0 | 0.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.4 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 1.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.0 | 0.1 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.0 | 0.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.0 | 0.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.0 | 0.1 | GO:0070997 | neuron death(GO:0070997) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.0 | 0.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.0 | 0.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.0 | 0.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.1 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.0 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.0 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.1 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.0 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.0 | 0.0 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.0 | 0.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.0 | 0.1 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.0 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.0 | 0.0 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.1 | GO:0072237 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) metanephric proximal tubule development(GO:0072237) metanephric distal tubule morphogenesis(GO:0072287) |
0.0 | 0.0 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.0 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.0 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.0 | 0.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
0.0 | 0.1 | GO:1990441 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.1 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.0 | 0.1 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.0 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.0 | 0.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 0.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.2 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.0 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.0 | 0.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.0 | 0.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.0 | 0.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 0.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0035698 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.0 | 0.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.6 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.0 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.4 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 1.2 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.0 | 0.0 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.0 | 0.1 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.0 | 0.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.1 | GO:0060191 | regulation of lipase activity(GO:0060191) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0030573 |